BCL2L11 and sarcoma: Across the sarcoma cell lines and PDCs tested in this study, the expression levels of PUMA and BIM were significantly upregulated by treatment with ZSTK474 in cell lines undergoing apoptosis, while PUMA and BIM expression was not induced in cell lines not undergoing apoptosis (Fig. S6).